Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 1

Results: 15

Aqueous metabolome of tissue‐specific conditional Pten‐knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma.

Published in:

Prostate, 2022, v. 82, n. 1, p. 154, doi. 10.1002/pros.24256

By:

Kim, Sangyub;
Li, Li;
Zhang, Jinhui;
Jiang, Cheng;
Lü, Junxuan

Publication type:

Article

Glycoforms of human prostate‐specific membrane antigen (PSMA) in human cells and prostate tissue.

Published in:

Prostate, 2022, v. 82, n. 1, p. 132, doi. 10.1002/pros.24254

By:

Yuan, Wei;
Liu, Baoqin;
Sanda, Miloslav;
Wei, Renhuizi;
Benicky, Julius;
Novakova, Zora;
Barinka, Cyril;
Goldman, Radoslav

Publication type:

Article

Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.

Published in:

Prostate, 2022, v. 82, n. 1, p. 59, doi. 10.1002/pros.24248

By:

Huang, Ru;
Liu, Yuhan;
Li, Bingsheng;
Wang, Ruixiao;
Tamalunas, Alexander;
Waidelich, Raphaela;
Strittmatter, Frank;
Stief, Christian G.;
Hennenberg, Martin

Publication type:

Article

Association of germline rare pathogenic mutations in guideline‐recommended genes with prostate cancer progression: A meta‐analysis.

Published in:

Prostate, 2022, v. 82, n. 1, p. 107, doi. 10.1002/pros.24252

By:

Shi, Zhuqing;
Lu, Lucy;
Resurreccion, William Kyle;
Yang, Wancai;
Wei, Jun;
Wang, Qiang;
Engelmann, Valentina;
Zheng, Siqun Lilly;
Cooney, Kathleen A.;
Isaacs, William B.;
Helfand, Brian T.;
Lu, Jim;
Xu, Jianfeng

Publication type:

Article

Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations.

Published in:

Prostate, 2022, v. 82, n. 1, p. 145, doi. 10.1002/pros.24255

By:

Şeref, Ceren;
Acar, Ömer;
Kılıç, Mert;
Vural, Metin;
Sağlıcan, Yeşim;
Saraç, Hilal;
Coşkun, Bilgen;
İnce, Ümit;
Esen, Tarık;
Lack, Nathan A.

Publication type:

Article

Cancer‐specific survival after radical prostatectomy versus external beam radiotherapy in high‐risk and very high‐risk African American prostate cancer patients.

Published in:

Prostate, 2022, v. 82, n. 1, p. 120, doi. 10.1002/pros.24253

By:

Hoeh, Benedikt;
Würnschimmel, Christoph;
Flammia, Rocco S.;
Horlemann, Benedikt;
Sorce, Gabriele;
Chierigo, Francesco;
Tian, Zhe;
Saad, Fred;
Graefen, Markus;
Gallucci, Michele;
Briganti, Alberto;
Terrone, Carlo;
Shariat, Shahrokh F.;
Kluth, Luis A.;
Mandel, Philipp;
Chun, Felix K. H.;
Karakiewicz, Pierre I.

Publication type:

Article

AT‐rich interaction domain 5A regulates the transcription of interleukin‐6 gene in prostate cancer cells.

Published in:

Prostate, 2022, v. 82, n. 1, p. 97, doi. 10.1002/pros.24251

By:

Ikeuchi, Wataru;
Wakita, Yuriko;
Zhang, Guoxiang;
Li, Chun;
Itakura, Keiichi;
Yamakawa, Takahiro

Publication type:

Article

Restoration of erectile function by a combination of antiapoptosis by JNK inhibitor and preservation of smooth muscle or endothelium by hepatocyte growth factor in a rat model of cavernous nerve injury.

Published in:

Prostate, 2022, v. 82, n. 1, p. 49, doi. 10.1002/pros.24247

By:

Kim, Soo Woong;
Lee, Junghoon;
Oh, Sohee;
Son, Hwancheol;
Cho, Min Chul

Publication type:

Article

Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA‐targeted radioligand therapy.

Published in:

Prostate, 2022, v. 82, n. 1, p. 86, doi. 10.1002/pros.24250

By:

Widjaja, Liam;
Derlin, Thorsten;
Ross, Tobias L.;
Bengel, Frank M.;
Werner, Rudolf A.

Publication type:

Article

Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients.

Published in:

Prostate, 2022, v. 82, n. 1, p. 78, doi. 10.1002/pros.24249

By:

Wenzel, Mike;
Collà Ruvolo, Claudia;
Würnschimmel, Christoph;
Nocera, Luigi;
Tian, Zhe;
Saad, Fred;
Briganti, Alberto;
Tilki, Derya;
Graefen, Markus;
Becker, Andreas;
Roos, Frederik;
Mandel, Philipp;
Chun, Felix K. H.;
Karakiewicz, Pierre I.

Publication type:

Article

Prognostic role of 11C‐choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy.

Published in:

Prostate, 2022, v. 82, n. 1, p. 41, doi. 10.1002/pros.24246

By:

Jimbo, Masaya;
Andrews, Jack R.;
Ahmed, Mohamed E.;
Dundar, Ayca;
Karnes, R. Jeffrey;
Bryce, Alan H.;
Kendi, Ayse T.;
Kwon, Eugene D.;
Lowe, Val J.;
Bold, Michael S.

Publication type:

Article

Regulatory mechanism of androgen receptor on NCAPD3 gene expression in prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 1, p. 26, doi. 10.1002/pros.24245

By:

Yin, Yingying;
Liu, Qianmei;
Shao, Yingying;
He, Xinyuan;
Zhu, Qingyi;
Lu, Shan;
Liu, Ping

Publication type:

Article

Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms.

Published in:

Prostate, 2022, v. 82, n. 1, p. 13, doi. 10.1002/pros.24244

By:

Teoh, Jeremy Yuen‐Chun;
Tian, Xiao‐Yu;
Wong, Christine Yim‐Ping;
Lau, Chi‐Wai;
Cheng, Chak‐Kwong;
Tang, Victor Wai‐Lun;
Chan, Ronald Cheong‐Kin;
Huang, Yu;
Ng, Chi‐Fai

Publication type:

Article

Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 1, p. 3, doi. 10.1002/pros.24243

By:

Yanagisawa, Takafumi;
Kimura, Takahiro;
Mori, Keiichiro;
Suzuki, Hirotaka;
Sano, Takayuki;
Otsuka, Takashi;
Iwamoto, Yuya;
Fukuokaya, Wataru;
Miyajima, Keiichiro;
Enei, Yuki;
Sakanaka, Keigo;
Matsukawa, Akihiro;
Onuma, Hajime;
Obayashi, Koki;
Tsuzuki, Shunsuke;
Hata, Kenichi;
Shimomura, Tatsuya;
Miki, Jun;
Egawa, Shin

Publication type:

Article

Issue Information.

Published in:: Prostate, 2022, v. 82, n. 1, p. 1, doi. 10.1002/pros.24151
Publication type:: Article